L&C BIO Co.,LTD (KOSDAQ:290650)
64,200
-6,800 (-9.58%)
Jul 20, 2026, 3:30 PM KST
115.08% (1Y)
| Market Cap | 1.73T +125.4% |
| Revenue (ttm) | 98.10B +34.1% |
| Net Income | -135.14B |
| EPS | -5,627.49 |
| Shares Out | 26.97M |
| PE Ratio | n/a |
| Forward PE | 57.25 |
| Dividend | 50.00 (0.07%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 286,227 |
| Open | 69,500 |
| Previous Close | 71,000 |
| Day's Range | 61,700 - 71,700 |
| 52-Week Range | 28,150 - 125,000 |
| Beta | 1.36 |
| Analysts | Buy |
| Price Target | 99,000.00 (+54.21%) |
| Earnings Date | Aug 14, 2026 |